Related references
Note: Only part of the references are listed.Structures of Triacetyloleandomycin and Mycalamide A Bind to the Large Ribosomal Subunit of Haloarcula marismortui
Guliz Gurel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Coordinate control of lipid composition and drug transport activities is required for normal multidrug resistance in fungi
Puja Shahi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Pederin-Type Pathways of Uncultivated Bacterial Symbionts: Analysis of O-Methyltransferases and Generation of a Biosynthetic Hybrid
Katrin Zimmermann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
The Discovery of Potent Antitumor Agent C11-Deoxypsymberin/irciniastatin A: Total Synthesis and Biology of Advanced Psymberin Analogs
Xianhai Huang et al.
ORGANIC LETTERS (2009)
Total synthesis of theopederin D
Michael E. Green et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors
Alexander Stepanov et al.
MOLECULAR PHARMACOLOGY (2008)
Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks
Dibyendu Banerjee et al.
EUKARYOTIC CELL (2008)
The central role of PDR1 in the foundation of yeast drug resistance
Vivienne Fardeau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Synthesis of psymberin analogues: Probing a functional correlation with the pederin/mycalamide family of natural products
Xin Jiang et al.
ORGANIC LETTERS (2007)
Total synthesis of pederin
John C. Jewett et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Adaptive response to the antimalarial drug artesunate in yeast involves Pdr1p/Pdr3p-mediated transcriptional activation of the resistance determinants TPO1 and PDR5
Marta Alenquer et al.
FEMS YEAST RESEARCH (2006)
Human multidrug resistance ABCB and ABCG transporters:: Participation in a chemoimmunity defense system
Balazs Sarkadi et al.
PHYSIOLOGICAL REVIEWS (2006)
Convergent total synthesis of (+)-mycalamide A
Natsuko Kagawa et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
Privileged structures as leads in medicinal chemistry
L Costantino et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Inhibition of protein synthesis and activation of stress-activated protein kinases by onnamide A and theopederin B, antitumor marine natural products
KH Lee et al.
CANCER SCIENCE (2005)
Total synthesis of mycalamide A
JH Sohn et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug-resistant cell lines
TN Gaitanos et al.
CANCER RESEARCH (2004)
Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei
J Piel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Three-dimensional reconstruction of the Saccharomyces cerevisiae multidrug resistance protein Pdr5p
A Ferreira-Pereira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine
KA Hood et al.
APOPTOSIS (2001)
Onnamide F:: A new nematocide from a southern Australian marine sponge, Trachycladus laevispirulifer
D Vuong et al.
JOURNAL OF NATURAL PRODUCTS (2001)
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants
J DeRisi et al.
FEBS LETTERS (2000)